2008
DOI: 10.1016/j.nmd.2008.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Acquired multiple Acyl-CoA dehydrogenase deficiency in 10 horses with atypical myopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
127
1
2

Year Published

2013
2013
2023
2023

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 80 publications
(136 citation statements)
references
References 15 publications
6
127
1
2
Order By: Relevance
“…Previous studies 11,14,15 reported increased levels of most of the up to 35 carnitines tested in plasma or serum. With the serum samples available in our laboratory, we received similar results by parent ion scans of m/z 85 fragments in a spectrum of 32 carnitines (not shown).…”
Section: Discussionmentioning
confidence: 89%
See 2 more Smart Citations
“…Previous studies 11,14,15 reported increased levels of most of the up to 35 carnitines tested in plasma or serum. With the serum samples available in our laboratory, we received similar results by parent ion scans of m/z 85 fragments in a spectrum of 32 carnitines (not shown).…”
Section: Discussionmentioning
confidence: 89%
“…Analyzing urine or plasma samples for acyl glycines, including MCPA glycine, should therefore also be a way to prove HGA intoxication. Previous studies 11,12,15 described qualitatively positive results for butyryl, isovaleryl, and hexanoyl glycines in the urine of poisoned horses. One study 10 extracted glycine conjugates by liquid partition chromatography and transferred them, as in a previous study, 15 to trimethylsilyl derivatives.…”
Section: Introductionmentioning
confidence: 92%
See 1 more Smart Citation
“…This acquired equine MADD is associated with a substantial elevation of C2-, C3-, C4-, C5-, C6-, C8-, C8:1-, C10:1-and C10:2-carnitine concentrations in plasma in the majority of cases (Westermann et al 2008a). As single carnitine supplementation increases the utilization of C5-and C8-carnitne in healthy horses, it is a plausible idea to use it in horses affected with MADD and other potential fatty acid oxidation disorders (Wijnberg et al 2008).…”
Section: Acylcarnitinesmentioning
confidence: 98%
“…In animals, outbreaks of fatal MADD have been recorded in horses with atypical myopathy in particular weather conditions (Finno et al 2006;Cassart et al 2007;Westermann et al 2008;van der Kolk et al 2010;Valberg et al 2012). In these cases, an exogenous factor was predicted to cause MADD, and a genetic mutation of ETF and ETFDH has never been recognized.…”
Section: Introductionmentioning
confidence: 99%